Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin + Gemcitabine + 5FU/FA vs Avastin + FOLFOX4 in Metastatic Colorectal Cancer
NCT00192075Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jun 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine in metastatic colorectal cancer (mCRC), sponsored by Eli Lilly and Company. Started Jun 2003; status: completed.
02
Drugs
gemcitabine
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00192075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00192075.